 | Up a level |
Journal Article
Mohabati, Danial, Schellevis, Rosa L., Van Dijk, Elon H. C., Altay, Lebriz, Fauser, Sascha, Hoyng, Carel B., De Jong, Eiko K., Boon, Camiel J. F. and Yzer, Suzanne (2019). GENETIC RISK FACTORS IN ACUTE CENTRAL SEROUS CHORIORETINOPATHY. Retin.-J. Retin. Vitr. Dis., 39 (12). S. 2303 - 2311. PHILADELPHIA: LIPPINCOTT WILLIAMS & WILKINS. ISSN 1539-2864
Mohabati, Danial, Van Dijk, Elon H. C., Talib, Mays, de Jong, Eiko, Fauser, Sascha, Hoyng, Carel C. B., Yzer, Suzanne and Boon, Camiel J. F. (2016). Clinical characteristics and response to photodynamic therapy in severe phenotypes of chronic central serous chorioretinopathy. Invest. Ophthalmol. Vis. Sci., 57 (12). ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC. ISSN 1552-5783
Schellevis, Roos, Breukink, Myrte, Van Dijk, Elon H. C., Fauser, Sascha, Boon, Camiel J. F., de Jong, Eiko and Den Hollander, Anneke I. (2016). Association analysis of functional variants in blood pressure regulation, blood clot formation and stress hormone binding genes with chronic central serous chorioretinopathy (cCSC). Invest. Ophthalmol. Vis. Sci., 57 (12). ROCKVILLE: ASSOC RESEARCH VISION OPHTHALMOLOGY INC. ISSN 1552-5783
Van Rijssen, Thomas J., Van Dijk, Elon H. C., Scholz, Paula, Breukink, Myrte B., Blanco-Garavito, Rocio, Ied, Eric H. Sou, Keunen, Jan E. E., Maclaren, Robert E., Querques, Giuseppe, Fauser, Sascha, Downes, Susan M., Hoyng, Carel B. and Boon, Camiel J. F. (2019). Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3. Am. J. Ophthalmol., 205. S. 1 - 11. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-1891
Van Rijssen, Thomas J., Van Dijk, Elon H. C., Scholz, Paula, Breukink, Myrte B., Blanco-Garavito, Rocio, Souied, Eric H., Keunen, Jan E. E., Maclaren, Robert E., Querques, Giuseppe, Fauser, Sascha, Downes, Susan M., Hoyng, Carel B. and Boon, Camiel J. F. (2020). Reply to Comment on: Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3. Am. J. Ophthalmol., 212. S. 187 - 190. NEW YORK: ELSEVIER SCIENCE INC. ISSN 1879-1891